Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 14.51% is 151% above its 5-year average of -28.47%, near the high end of its 5-year range (-132.01%–14.80%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.82% above its 12-month average of 12.42%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 14.51%.
RETURN ON EQUITY (ROE)
14.51%
RETURN ON EQUITY (ROE) AVG TTM
12.42%
RETURN ON EQUITY (ROE) AVG 3Y
-5.41%
RETURN ON EQUITY (ROE) AVG 5Y
-28.47%
RETURN ON EQUITY (ROE) AVG 10Y
-46.33%
RETURN ON EQUITY (ROE) AVG 15Y
-84.63%
RETURN ON EQUITY (ROE) AVG 20Y
-128.28%
CURRENT VS TTM AVG
+16.82%
CURRENT VS 3Y AVG
+368.04%
CURRENT VS 5Y AVG
+150.95%
CURRENT VS 10Y AVG
+131.31%
CURRENT VS 15Y AVG
+117.14%
CURRENT VS 20Y AVG
+111.31%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+134.53%
vs the sector median at left
Nephros, Inc.
Market Cap
$38.00M
Return on Equity (ROE)
14.51%
TTM Avg
12.42%
3Y Avg
-5.41%
5Y Avg
-28.47%
Market Cap
$37.81M
Return on Equity (ROE)
-28.65%
TTM Avg
-189.41%
3Y Avg
-194.44%
5Y Avg
-158.64%
Market Cap
$38.47M
Return on Equity (ROE)
-140.36%
TTM Avg
-216.21%
3Y Avg
-112.57%
5Y Avg
-76.80%
Market Cap
$38.78M
Return on Equity (ROE)
-83.03%
TTM Avg
-44.32%
3Y Avg
5.07%
5Y Avg
17.23%
Market Cap
$36.42M
Return on Equity (ROE)
-819.34%
TTM Avg
-116.46%
3Y Avg
-74.90%
5Y Avg
-96.78%
Market Cap
$36.17M
Return on Equity (ROE)
-160.05%
TTM Avg
-184.57%
3Y Avg
-168.71%
5Y Avg
-141.15%
Market Cap
$36.70M
Return on Equity (ROE)
N/A
TTM Avg
333.35%
3Y Avg
376.86%
5Y Avg
270.78%
Market Cap
$40.37M
Return on Equity (ROE)
-47.96%
TTM Avg
-120.47%
3Y Avg
-203.88%
5Y Avg
-145.61%
Market Cap
$35.46M
Return on Equity (ROE)
-476.77%
TTM Avg
-979.99%
3Y Avg
-646.46%
5Y Avg
-421.61%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nephros, Inc. (NEPH) | $38.00M | 14.51% | 12.42% | -5.41% | -28.47% |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | -28.65% | -189.41% | -194.44% | -158.64% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | -140.36% | -216.21% | -112.57% | -76.80% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $38.78M | -83.03% | -44.32% | 5.07% | 17.23% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.42M | -819.34% | -116.46% | -74.90% | -96.78% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.17M | -160.05% | -184.57% | -168.71% | -141.15% |
| EUDA Health Holdings Limited (EUDA)vs › | $36.70M | N/A | 333.35% | 376.86% | 270.78% |
| Veru Inc. (VERU)vs › | $40.37M | -47.96% | -120.47% | -203.88% | -145.61% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.46M | -476.77% | -979.99% | -646.46% | -421.61% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.69M | -66.47% | -61.13% | -30.57% | -24.45% |
ROE
14.5%
ROA
11.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 14.51% |
| 2026-03-31 | 7.25% |
| 2025-12-31 | 11.70% |
| 2025-09-30 | 14.80% |
| 2025-06-30 | 13.82% |
| 2025-03-31 | 8.62% |
| 2024-12-31 | 0.86% |
| 2024-09-30 | -11.37% |
| 2024-06-30 | -16.33% |
| 2024-03-31 | -17.58% |
| 2023-12-31 | -18.84% |
| 2023-09-30 | -21.33% |
| 2023-06-30 | -56.48% |
| 2023-03-31 | -63.62% |
| 2022-12-31 | -132.01% |
| 2022-09-30 | -120.07% |
| 2022-06-30 | -60.28% |
| 2022-03-31 | -54.54% |
| 2021-12-31 | -35.12% |
| 2021-09-30 | -31.15% |
| 2021-06-30 | -30.78% |
| 2021-03-31 | -33.68% |
| 2020-12-31 | -38.06% |
| 2020-09-30 | -49.49% |
| 2020-06-30 | -42.07% |
| 2020-03-31 | -29.91% |
| 2019-12-31 | -73.16% |
| 2019-09-30 | -106.54% |
| 2019-06-30 | -97.34% |
| 2019-03-31 | -129.84% |
| 2018-12-31 | -89.57% |
| 2018-09-30 | -33.73% |
| 2018-06-30 | -32.33% |
| 2018-03-31 | -82.09% |
| 2017-12-31 | -41.49% |
| 2017-06-30 | -361.05% |
| 2017-03-31 | -209.32% |
| 2016-12-31 | -454.57% |
| 2016-09-30 | -272.14% |
| 2016-06-30 | -190.50% |
| 2016-03-31 | -209.08% |
| 2015-12-31 | -115.92% |
| 2015-09-30 | -265.19% |
| 2014-03-31 | -419.97% |
| 2013-09-30 | -842.33% |
| 2013-06-30 | -459.45% |
| 2012-09-30 | -867.49% |
| 2012-06-30 | -263.32% |
| 2012-03-31 | -213.73% |
| 2011-12-31 | -166.08% |
| 2011-09-30 | -128.82% |
| 2011-06-30 | -105.43% |
| 2011-03-31 | -75.92% |
| 2010-09-30 | -219.42% |
| 2010-06-30 | -164.74% |
| 2010-03-31 | -128.82% |
| 2009-12-31 | -103.47% |
| 2009-09-30 | -101.58% |
| 2009-06-30 | -240.86% |
| 2009-03-31 | -308.46% |
| 2008-12-31 | -250.08% |
| 2008-09-30 | -796.33% |
| 2008-06-30 | -565.83% |
| 2008-03-31 | -365.54% |
| 2007-12-31 | -301.01% |
| 2006-06-30 | -381.96% |
| 2006-03-31 | -189.25% |
| 2005-12-31 | -101.65% |
| 2005-09-30 | -92.70% |
| 2005-06-30 | -75.86% |
| 2005-03-31 | -59.38% |
